Xcyte Therapies Inc., Spiro Rombotis,

A publisher of Business Information since 1983

| Sign In | Hints

Company Name

Xcyte Therapies Inc.

Address

150 JFK Parkway
Suite 100
Short Hills, New Jersey 07078
United States

Email	ir@xcytetherapies.com	Phone	1-973-847-5955
Website	www.cyclacel.com	Fax	1-866-271-3466

Business Information

The group�s principle activities include developing and commercializing novel, mechanism-targeted drugs to treat human cancers and other serious disorders. The group�s products include Sapacitabine, Aurora Kinase and VEGFR2 inhibitor, and Seliciclib. The group operates from United States.

Executive Information
Name	Title	Email
David U�prichard	Chmn.	N/A
Gregory Reyes	Sr. VP - Research	N/A
John Womelsdorf	VP - Business Development	N/A
Judy Chiao	VP - Clinical Development, Regulatory Affairs	N/A
Paul McBarron	Exec. VP - Finance, COO, Sec., Dir.	N/A

Financial Information ( All figures in $ '000 )
Year	Sales	Net Income
2006	387	(29,258)
2005	813	(29,416)
2004	62	(39,588)

TO SEE COMPLETE RESULTS SUBSCRIBE NOW

Click for more Executives

Home \| About Us \| Product Information \| Subscription \| List Builder \| Executive List \| Email Lists \| Contact Us \| Site Map \| Browse Directory

© 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.